209 related articles for article (PubMed ID: 19305429)
1. NAC-1, a potential stem cell pluripotency factor, contributes to paclitaxel resistance in ovarian cancer through inactivating Gadd45 pathway.
Jinawath N; Vasoontara C; Yap KL; Thiaville MM; Nakayama K; Wang TL; Shih IM
Oncogene; 2009 May; 28(18):1941-8. PubMed ID: 19305429
[TBL] [Abstract][Full Text] [Related]
2. CRM197 reverses paclitaxel resistance by inhibiting the NAC-1/Gadd45 pathway in paclitaxel-resistant ovarian cancer cells.
Tang XH; Li H; Zheng XS; Lu MS; An Y; Zhang XL
Cancer Med; 2019 Oct; 8(14):6426-6436. PubMed ID: 31490008
[TBL] [Abstract][Full Text] [Related]
3. A BTB/POZ gene, NAC-1, a tumor recurrence-associated gene, as a potential target for Taxol resistance in ovarian cancer.
Ishibashi M; Nakayama K; Yeasmin S; Katagiri A; Iida K; Nakayama N; Fukumoto M; Miyazaki K
Clin Cancer Res; 2008 May; 14(10):3149-55. PubMed ID: 18483383
[TBL] [Abstract][Full Text] [Related]
4. NAC-1 controls cell growth and survival by repressing transcription of Gadd45GIP1, a candidate tumor suppressor.
Nakayama K; Nakayama N; Wang TL; Shih IeM
Cancer Res; 2007 Sep; 67(17):8058-64. PubMed ID: 17804717
[TBL] [Abstract][Full Text] [Related]
5. Nucleus accumbens-1/GADD45GIP1 axis mediates cisplatin resistance through cellular senescence in ovarian cancer.
Nakayama K; Rahman M; Rahman MT; Nakamura K; Sato E; Katagiri H; Ishibashi T; Ishikawa M; Iida K; Razia S; Ishikawa N; Kyo S
Oncol Lett; 2017 Jun; 13(6):4713-4719. PubMed ID: 28599472
[TBL] [Abstract][Full Text] [Related]
6. Nucleus Accumbens 1, a Pox virus and Zinc finger/Bric-a-brac Tramtrack Broad protein binds to TAR DNA-binding protein 43 and has a potential role in Amyotrophic Lateral Sclerosis.
Scofield MD; Korutla L; Jackson TG; Kalivas PW; Mackler SA
Neuroscience; 2012 Dec; 227():44-54. PubMed ID: 23022214
[TBL] [Abstract][Full Text] [Related]
7. Expression of the bric-a-brac tramtrack broad complex protein NAC-1 in cervical carcinomas seems to correlate with poorer prognosis.
Yeasmin S; Nakayama K; Ishibashi M; Katagiri A; Iida K; Purwana IN; Nakayama N; Miyazaki K
Clin Cancer Res; 2008 Mar; 14(6):1686-91. PubMed ID: 18347169
[TBL] [Abstract][Full Text] [Related]
8. iASPP and chemoresistance in ovarian cancers: effects on paclitaxel-mediated mitotic catastrophe.
Jiang L; Siu MK; Wong OG; Tam KF; Lu X; Lam EW; Ngan HY; Le XF; Wong ES; Monteiro LJ; Chan HY; Cheung AN
Clin Cancer Res; 2011 Nov; 17(21):6924-33. PubMed ID: 21926165
[TBL] [Abstract][Full Text] [Related]
9. NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response.
Zhang Y; Cheng Y; Ren X; Zhang L; Yap KL; Wu H; Patel R; Liu D; Qin ZH; Shih IM; Yang JM
Oncogene; 2012 Feb; 31(8):1055-64. PubMed ID: 21743489
[TBL] [Abstract][Full Text] [Related]
10. Expression and clinical role of the bric-a-brac tramtrack broad complex/poxvirus and zinc protein NAC-1 in ovarian carcinoma effusions.
Davidson B; Berner A; Trope' CG; Wang TL; Shih IM
Hum Pathol; 2007 Jul; 38(7):1030-1036. PubMed ID: 17391728
[TBL] [Abstract][Full Text] [Related]
11. A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival.
Nakayama K; Nakayama N; Davidson B; Sheu JJ; Jinawath N; Santillan A; Salani R; Bristow RE; Morin PJ; Kurman RJ; Wang TL; Shih IeM
Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18739-44. PubMed ID: 17130457
[TBL] [Abstract][Full Text] [Related]
12. TLR4 and NFκB signaling is critical for taxol resistance in ovarian carcinoma cells.
Sun NK; Huang SL; Chang TC; Chao CC
J Cell Physiol; 2018 Mar; 233(3):2489-2501. PubMed ID: 28771725
[TBL] [Abstract][Full Text] [Related]
13. [Expression and significance of heparin binding-epidermal growth factor-like growth factor in paclitaxel-resistant ovarian cancer].
Tang X; Lu M; Li C; Deng S; Li M
Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):517-22. PubMed ID: 25327734
[TBL] [Abstract][Full Text] [Related]
14. [Reverse of the resistance to paclitaxel of the heparin binding-epidermal growth factor-like growth factor inhibitor in ovarian cancer].
Tang XH; Lu MS; Deng S; Li M
Zhonghua Fu Chan Ke Za Zhi; 2017 Feb; 52(2):110-115. PubMed ID: 28253574
[No Abstract] [Full Text] [Related]
15. The role of the MAD2-TLR4-MyD88 axis in paclitaxel resistance in ovarian cancer.
Bates M; Spillane CD; Gallagher MF; McCann A; Martin C; Blackshields G; Keegan H; Gubbins L; Brooks R; Brooks D; Selemidis S; O'Toole S; O'Leary JJ
PLoS One; 2020; 15(12):e0243715. PubMed ID: 33370338
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of 11q13.5 amplicon identifies Rsf-1 (HBXAP) as a gene involved in paclitaxel resistance in ovarian cancer.
Choi JH; Sheu JJ; Guan B; Jinawath N; Markowski P; Wang TL; Shih IeM
Cancer Res; 2009 Feb; 69(4):1407-15. PubMed ID: 19190325
[TBL] [Abstract][Full Text] [Related]
17. [Preliminary study of the prohibitin protein and paclitaxel resistance in ovarian cancer].
Tang J; Cao L; Yi H; Tang C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Dec; 37(12):1221-7. PubMed ID: 23281375
[TBL] [Abstract][Full Text] [Related]
18. Expression of organic anion-transporting polypeptides 1B1 and 1B3 in ovarian cancer cells: relevance for paclitaxel transport.
Svoboda M; Wlcek K; Taferner B; Hering S; Stieger B; Tong D; Zeillinger R; Thalhammer T; Jäger W
Biomed Pharmacother; 2011 Sep; 65(6):417-26. PubMed ID: 21719246
[TBL] [Abstract][Full Text] [Related]
19. NAC1 attenuates BCL6 negative autoregulation and functions as a BCL6 coactivator of FOXQ1 transcription in cancer cells.
Gao M; Herlinger AL; Wu R; Wang TL; Shih IM; Kong B; Rangel LBA; Yang JM
Aging (Albany NY); 2020 May; 12(10):9275-9291. PubMed ID: 32412910
[TBL] [Abstract][Full Text] [Related]
20. Nac1 interacts with the POZ-domain transcription factor, Miz1.
Stead MA; Wright SC
Biosci Rep; 2014 Jun; 34(3):. PubMed ID: 24702277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]